Literature DB >> 20890945

The role of intestinal endotoxin in liver injury: a long and evolving history.

James P Nolan1.   

Abstract

From the mid-1950s, it was observed that liver injury by a variety of toxins greatly sensitized the host to the effects of administered lipopolysaccharide. In the nutritional cirrhosis of choline deficiency, and in acute toxic injury as well, the need for the presence of enteric endotoxin was demonstrated. The universality of this association was striking for almost all agents associated with liver injury. In addition, the presence of endotoxemia in human liver disease was documented in the 1970s, when the hypothesis was first proposed, and correlated with the severity of the disease. Despite imposing evidence of the critical role of enteric endotoxin in liver injury, it did not excite much interest in investigators until the 1980s. With the ability to study effects of alcohol in newer delivery systems, and an increased understanding of the role of Kupffer cells in the process, the original hypothesis has been accepted. This historical review details the progress of this novel concept of disease initiation and suggests future directions to bring potential therapies to the bedside.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20890945     DOI: 10.1002/hep.23917

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  82 in total

1.  Beyond pattern recognition: five immune checkpoints for scaling the microbial threat.

Authors:  J Magarian Blander; Leif E Sander
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

2.  β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.

Authors:  Yonglin Chen; Xinshou Ouyang; Rafaz Hoque; Irma Garcia-Martinez; Muhammad Nadeem Yousaf; Sarah Tonack; Stefan Offermanns; Laurent Dubuquoy; Alexandre Louvet; Philippe Mathurin; Veronica Massey; Bernd Schnabl; Ramon Alberola Bataller; Wajahat Zafar Mehal
Journal:  J Hepatol       Date:  2018-04-27       Impact factor: 25.083

Review 3.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

4.  Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program.

Authors:  Irina A Kirpich; Craig J McClain; Vatsalya Vatsalya; Melanie Schwandt; Monte Phillips; Keith Cameron Falkner; Lucy Zhang; Catey Harwell; David T George; John C Umhau
Journal:  Alcohol Clin Exp Res       Date:  2017-03-02       Impact factor: 3.455

5.  Protective effect of Salvia miltiorrhiza and Carthamus tinctorius extract against lipopolysaccharide-induced liver injury.

Authors:  Li-Na Gao; Kuo Yan; Yuan-Lu Cui; Guan-Wei Fan; Yue-Fei Wang
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

Review 6.  A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease.

Authors:  Zhi Zhong; John J Lemasters
Journal:  Alcohol Clin Exp Res       Date:  2018-09-17       Impact factor: 3.455

7.  Endotoxemia as a trigger of thrombosis in cirrhosis.

Authors:  Francesco Violi; Gregory Y H Lip; Roberto Cangemi
Journal:  Haematologica       Date:  2016-04       Impact factor: 9.941

Review 8.  Regulation of wound healing and organ fibrosis by toll-like receptors.

Authors:  Peter Huebener; Robert F Schwabe
Journal:  Biochim Biophys Acta       Date:  2012-12-04

Review 9.  Early warning and clinical outcome prediction of acute-on-chronic hepatitis B liver failure.

Authors:  En-Qiang Chen; Fan Zeng; Ling-Yun Zhou; Hong Tang
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  A pathogenetic link between non-alcoholic fatty liver disease and celiac disease.

Authors:  Ludovico Abenavoli; Natasa Milic; Antonino De Lorenzo; Francesco Luzza
Journal:  Endocrine       Date:  2012-06-28       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.